Illustration showing rod-shaped Mycobacterium tuberculosis bacteria in the lungs of a person with tuberculosis
Delayed T cell Response Allows Tuberculosis to Gain Foothold in Monkeys
The results could help guide the design of new vaccines for the disease.
Delayed T cell Response Allows Tuberculosis to Gain Foothold in Monkeys
Delayed T cell Response Allows Tuberculosis to Gain Foothold in Monkeys

The results could help guide the design of new vaccines for the disease.

The results could help guide the design of new vaccines for the disease.

latent infection
Experimental TB Vaccine Partially Effective: Study
Ashley Yeager | Oct 30, 2019
Tested in patients with the latent form of tuberculosis, the vaccine prevented the development of the active form of infection in 50 percent more individuals compared with unvaccinated patients.
 immunotherapy  treatment may cause latent infections of Mycobacterium tuberculosis to flare up in cancer patients
Tuberculosis Can Emerge After Cancer Immunotherapy
Ashley Yeager | Apr 1, 2019
At least a handful of patients have developed active TB after receiving cancer treatment designed to boost the immune system’s antitumor response.
CRISPR Combats Herpes
Alison F. Takemura | Jul 5, 2016
Scientists use the gene editing technology to target active and latent virus in mammalian cell cultures.
Hidden Menace
John Frater, Genevieve Martin, and Matthew Pace | May 1, 2015
Curing HIV means finding and eradicating viruses still lurking in the shadows.
Hiding in the Haystack
Mary Beth Aberlin | May 1, 2015
Encouraging developments in HIV research
Hide and Seek
The Scientist Staff | Apr 30, 2015
Oxford researcher John Frater explains the strategy of targeting viral reservoirs to beat HIV.